Sept 23, 2021 ACIP Meeting – COVID-19 vaccine booster doses Benefit/risk discussion

COVID-19 vaccine booster doses: Benefit/risk discussion; Evidence to Recommendation Framework: Booster doses of Pfizer-BioNTech COVID-19 vaccine; Clinical considerations; Discussions

This video can also be viewed at